NCT03646123 2025-08-28Clinical Trial of Brentuximab Vedotin in Classical Hodgkin LymphomaSeagen Inc.Phase 2 Terminated255 enrolled 29 charts
NCT00087776 2025-07-23Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant MelanomaAmerican Regent, Inc.Phase 3 Terminated393 enrolled